| Seizures, Focal

Aptiom vs Xcopri

Side-by-side clinical, coverage, and cost comparison for seizures, focal.
Deep comparison between: Aptiom vs Xcopri with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsXcopri has a higher rate of injection site reactions vs Aptiom based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Xcopri but not Aptiom, including UnitedHealthcare
Sign up to reveal the full AI analysis
Aptiom
Xcopri
At A Glance
Oral
Once daily
Sodium channel inhibitor
Oral
Once daily
Sodium channel inhibitor / GABA-A modulator
Indications
  • Seizures, Focal
  • Seizures, Focal
Dosing
Seizures, Focal (Adults) Initial 400 mg orally once daily; may initiate at 800 mg once daily if need for seizure reduction outweighs increased adverse reaction risk; increase weekly by 400-600 mg to recommended maintenance of 800-1600 mg once daily.
Seizures, Focal (Pediatric, 4-17 years) Weight-based once daily oral dosing; initial dose and titration increments per weight table; maintenance 400-1200 mg/day depending on body weight range (11-21 kg: 400-600 mg; 22-31 kg: 500-800 mg; 32-38 kg: 600-900 mg; >38 kg: 800-1200 mg).
Renal Impairment (Moderate or Severe) Reduce dosage by 50% in patients with creatinine clearance below 50 mL/min.
Seizures, Focal Initiate at 12.5 mg once daily and titrate every 2 weeks to recommended maintenance dose of 200 mg once daily (oral); maximum 400 mg once daily; for mild to moderate hepatic impairment, maximum 200 mg once daily.
Contraindications
  • Hypersensitivity to eslicarbazepine acetate or oxcarbazepine
  • Hypersensitivity to cenobamate or any of the inactive ingredients in XCOPRI
  • Familial Short QT syndrome
Adverse Reactions
Most common (>=4%) dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor
Serious suicidal behavior and ideation, serious dermatologic reactions, DRESS/multiorgan hypersensitivity, anaphylactic reactions and angioedema, hyponatremia, drug-induced liver injury, abnormal thyroid function, pancytopenia, agranulocytosis, leukopenia
Postmarketing leukopenia, agranulocytosis, thrombocytopenia, megaloblastic anemia, pancytopenia, syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Most common (>=10%) Somnolence, dizziness, fatigue, diplopia, headache
Serious DRESS/multiorgan hypersensitivity, QT shortening, suicidal behavior and ideation, liver injury, neurological adverse reactions
Postmarketing Psychosis (hallucinations, delusions/paranoia), hostility, aggression, hepatic failure
Pharmacology
APTIOM is extensively converted to its active metabolite eslicarbazepine after oral administration; eslicarbazepine exerts anticonvulsant activity thought to involve inhibition of voltage-gated sodium channels.
Cenobamate reduces repetitive neuronal firing by inhibiting voltage-gated sodium currents and is also a positive allosteric modulator of the GABA-A ion channel; the precise mechanism by which these effects translate to seizure reduction in patients with partial-onset seizures is unknown.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Aptiom
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (0/12) · Qty limit (0/12)
View full coverage details ›
Xcopri
  • Covered on 5 commercial plans
  • PA (8/12) · Step Therapy (2/12) · Qty limit (11/12)
View full coverage details ›
UnitedHealthcare
Aptiom
  • Covered on 4 commercial plans
  • PA (6/8) · Step Therapy (0/8) · Qty limit (3/8)
View full coverage details ›
Xcopri
  • Covered on 4 commercial plans
  • PA (5/8) · Step Therapy (3/8) · Qty limit (2/8)
View full coverage details ›
Humana
Aptiom
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
View full coverage details ›
Xcopri
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
$35/fillfill
Aptiom High-Deductible Discount Card
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
$20/momo
Xcopri Coupon Card
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
AptiomView full Aptiom profile
XcopriView full Xcopri profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.